By Peter A. McCullough, MD, MPH
In clinical medicine there are always many ways to successfully treat patients. That is why no two doctors agree on the same exact treatment plan. The SARS-CoV-2 outbreak and COVID-19 pandemic called for innovation working around government imposed constraints.
Watch this exclusive interview with internist Sean Downing, MD, on his rationale for a triple combination of medications that addressed a key part of COVID-19 illness, that is, multisystem inflammation. Here is an excerpt from his manuscript:
Listen to this episode with a 7-day free trial
Subscribe to Courageous Discourse™ with Dr. Peter McCullough & John Leake to listen to this post and get 7 days of free access to the full post archives.
